A 42-year-old male with severe plaque psoriasis and psoriatic arthritis has failed topical therapies and phototherapy. He has a positive tuberculin skin test and chest X-ray findings consistent with latent tuberculosis. Initiation of which of the following biologic agents would carry the highest risk of tuberculosis reactivation, thus mandating pretreatment?
-
A
Secukinumab
-
B
Infliximab
-
C
Ustekinumab
-
D
Brodalumab